ARK Genomic Revolution ETF (ARKG)
ETF · Equity · ARK · Data as of 2026-10-22
Bottom line
ARKG is an ARK fund built around one theme, for 0.75% a year. Over the past year its price rose 46.6%, 32.8 points ahead of the S&P 500. It paid nothing out in the past 12 months. Past returns are not a guarantee of future results.
Fund facts
Fee: 0.75% a year
Assets: $2.2B
Holdings: 10
Payouts, past 12 months: 0.0%
Past year
46.57% price · 46.57% with payouts
About the fund
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.
Related funds
一句话结论
ARKG 是 ARK 旗下围绕单一主题的基金，年费率 0.75%。过去一年价格上涨 46.6%，领先标普 500 32.8 个百分点。过去 12 个月没有派息。过往表现并不能保证未来的结果。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.